The Impact of Long COVID-19 on Muscle Health.

Aging Body composition COVID-19 Muscle function Muscle mass Muscle strength Postacute COVID-19 syndrome Quality of life

Journal

Clinics in geriatric medicine
ISSN: 1879-8853
Titre abrégé: Clin Geriatr Med
Pays: United States
ID NLM: 8603766

Informations de publication

Date de publication:
08 2022
Historique:
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: ppublish

Résumé

COVID-19 negatively impacts several organs and systems weeks or months after initial diagnosis. Skeletal muscle can be affected, leading to fatigue, lower mobility, weakness, and poor physical performance. Older adults are at increased risk of developing musculoskeletal symptoms during long COVID. Systemic inflammation, physical inactivity, and poor nutritional status are some of the mechanisms leading to muscle dysfunction in individuals with long COVID. Current evidence suggests that long COVID negatively impacts body composition, muscle function, and quality of life. Muscle mass and function assessments can contribute toward the identification, diagnosis, and management of poor muscle health resulting from long COVID.

Identifiants

pubmed: 35868672
pii: S0749-0690(22)00004-0
doi: 10.1016/j.cger.2022.03.004
pmc: PMC8934728
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

545-557

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

ERJ Open Res. 2021 May 24;7(2):
pubmed: 34041295
Clin Nutr. 2022 Dec;41(12):3026-3031
pubmed: 34134915
Nutrients. 2021 Nov 06;13(11):
pubmed: 34836219
J Bone Joint Surg Am. 2020 Jul 15;102(14):1197-1204
pubmed: 32675661
JAMA Netw Open. 2021 Jan 4;4(1):e2036142
pubmed: 33502487
Clin Nutr. 2020 Jun;39(6):1631-1638
pubmed: 32305181
Diabetes Obes Metab. 2021 Sep;23(9):2183-2188
pubmed: 34060194
J Crit Care. 2021 Oct;65:36-41
pubmed: 34082253
BMJ. 2020 Aug 11;370:m3026
pubmed: 32784198
Eur Respir J. 2020 May 27;55(5):
pubmed: 32312864
Cardiovasc Diabetol. 2021 Aug 23;20(1):172
pubmed: 34425843
J Cachexia Sarcopenia Muscle. 2021 Feb;12(1):3-8
pubmed: 33382196
J Cachexia Sarcopenia Muscle. 2021 Oct;12(5):1203-1213
pubmed: 34196134
Clin Nutr ESPEN. 2020 Dec;40:214-219
pubmed: 33183539
Geroscience. 2020 Dec;42(6):1547-1578
pubmed: 33001410
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):3-19
pubmed: 29151281
Clin Nutr. 2022 Dec;41(12):2934-2939
pubmed: 34893357
Crit Care Med. 2021 Oct 1;49(10):1726-1738
pubmed: 33967204
Ir J Med Sci. 2022 Jun;191(3):969-975
pubmed: 34080125
J Med Virol. 2021 Apr;93(4):1852-1853
pubmed: 32975824
JAMA Intern Med. 2021 Jan 1;181(1):122-124
pubmed: 33196760
F1000Res. 2020 Nov 19;9:1349
pubmed: 33391730
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
PLoS One. 2021 May 14;16(5):e0251768
pubmed: 33989341
Clin Rheumatol. 2022 Jan;41(1):289-296
pubmed: 34713356
PLoS One. 2021 Aug 26;16(8):e0256142
pubmed: 34437579
Ann Clin Transl Neurol. 2021 Aug;8(8):1745-1749
pubmed: 34247452
J Med Virol. 2022 Jan;94(1):253-262
pubmed: 34463956
Aging Dis. 2020 Dec 1;11(6):1345-1351
pubmed: 33269092
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1399-1412
pubmed: 32893974
Clin Infect Dis. 2021 Sep 7;73(5):e1089-e1098
pubmed: 33220049
Crit Care Clin. 2018 Jan;34(1):107-125
pubmed: 29149933
Nature. 2020 Dec;588(7837):327-330
pubmed: 32942285
Aging Clin Exp Res. 2021 Oct;33(10):2887-2898
pubmed: 34328636
J Cachexia Sarcopenia Muscle. 2022 Feb;13(1):11-22
pubmed: 34997689
EBioMedicine. 2020 May;55:102763
pubmed: 32361250
EMBO Mol Med. 2021 Aug 9;13(8):e14150
pubmed: 34133077
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Front Physiol. 2020 Nov 19;11:597675
pubmed: 33329046
J Cachexia Sarcopenia Muscle. 2021 May 3;:
pubmed: 33939338
Health Qual Life Outcomes. 2021 Mar 17;19(1):90
pubmed: 33731093
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102302
pubmed: 34626924
World J Gastroenterol. 2006 Jun 7;12(21):3380-5
pubmed: 16733855
Infection. 2021 Dec;49(6):1163-1186
pubmed: 34319569
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Montserrat Montes-Ibarra (M)

Human Nutrition Research Unit, Department of Agricultural, Food, & Nutritional Science, University of Alberta, 113 Street and 87 Avenue NW, 2-004 Li Ka Shing Center for Health Research Innovation, Edmonton, Alberta, Canada.

Camila L P Oliveira (CLP)

Human Nutrition Research Unit, Department of Agricultural, Food, & Nutritional Science, University of Alberta, 113 Street and 87 Avenue NW, 2-004 Li Ka Shing Center for Health Research Innovation, Edmonton, Alberta, Canada.

Camila E Orsso (CE)

Human Nutrition Research Unit, Department of Agricultural, Food, & Nutritional Science, University of Alberta, 113 Street and 87 Avenue NW, 2-004 Li Ka Shing Center for Health Research Innovation, Edmonton, Alberta, Canada.

Francesco Landi (F)

Department of Geriatrics, Neurosciences and Orthopaedics, Catholic University of the Sacred Heart, Rome, Italy; Geriatric Department, Fondazione Policlinico Universitario Agostino Gemelli' IRCCS, Rome, Italy; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; Center for Geriatric Medicine (Ce.M.I.), Università Cattolica del Sacro Cuore, L.go F. Vito 1, Rome 00168, Italy.

Emanuele Marzetti (E)

Center for Geriatric Medicine (Ce.M.I.), Università Cattolica del Sacro Cuore, L.go F. Vito 1, Rome 00168, Italy; Department of Geriatrics and Orthopedics, Università Cattolica del Sacro Cuore, Rome, Italy; Orthogeriatric Unit, Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS, Rome, Italy.

Carla M Prado (CM)

Human Nutrition Research Unit, Department of Agricultural, Food, & Nutritional Science, University of Alberta, 113 Street and 87 Avenue NW, 2-004 Li Ka Shing Center for Health Research Innovation, Edmonton, Alberta, Canada. Electronic address: carla.prado@ualberta.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH